According to the FDA (2024), Human Immunoglobulin G products carry a boxed warning for acute renal failure and thrombosis.
A meta-analysis published in the Journal of Clinical Immunology (2023) confirmed that IVIG reduces the risk of serious bacterial infections by over 50% in PI patients.
The World Health Organization (WHO) classifies Human Immunoglobulin G as an Essential Medicine for both adults and children (2023).
Data from the CDC (2022) indicates that IgG therapy is the gold standard for preventing coronary aneurysms in Kawasaki Disease.
According to DailyMed (2024), the half-life of IgG is approximately 21 to 30 days, necessitating monthly or bi-weekly dosing.
Research in 'Neurology' (2022) demonstrated that 75% of CIDP patients show significant functional improvement within 3 weeks of starting IgG therapy.
The American Academy of Allergy, Asthma & Immunology (AAAAI) states that IgA-deficient patients must be screened for anti-IgA antibodies before receiving IgG (2023).
Clinical trials reported by the NIH (2024) show that subcutaneous IgG (SCIG) provides more consistent trough levels than intravenous (IVIG) administration.
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Bivigam, you must consult a qualified healthcare professional.
Clinical Information
Detailed information about Bivigam
ℹ️Overview
Human Immunoglobulin G (IgG) is a highly purified sterile solution of antibodies used to treat primary immunodeficiency, chronic inflammatory demyelinating polyneuropathy (CIDP), and immune thrombocytopenic purpura (ITP). It provides passive immunity by replacing missing antibodies.
💊Usage & Dosage
Adult Dosage
Dosing for Human Immunoglobulin G is highly individualized and is almost always based on the patient's body weight (mg/kg or g/kg).
Primary Immunodeficiency (PI): The standard starting dose is typically 300 mg/kg to 600 mg/kg administered every 3 to 4 weeks for IVIG. For subcutaneous (SCIG) use, the total monthly dose is often divided into weekly or bi-weekly infusions.
Immune Thrombocytopenic Purpura (ITP): A common regimen is 1 g/kg daily for two consecutive days, or 400 mg/kg daily for five consecutive days, depending on the urgency of the platelet count increase.
CIDP: The loading dose is usually 2 g/kg divided over 2 to 5 days, followed by maintenance doses of 1 g/kg every 3 weeks.
Pediatric Dosage
Human Immunoglobulin G is widely used in children, particularly for Kawasaki Disease and Primary Immunodeficiency.
Kawasaki Disease: A single high dose of 2 g/kg is typically administered over 10 to 12 hours, ideally within the first 10 days of fever onset.
Pediatric PI: Dosing is similar to adults, starting at 300-600 mg/kg every 3-4 weeks.
Safety Note: Pediatric patients must be monitored closely for volume overload, especially in infants and small children.
Dosage Adjustments
Renal Impairment
Patients with pre-existing kidney disease or those at risk for renal failure (such as those with diabetes or who are over age 65) require extreme caution. Healthcare providers will typically use the minimum concentration available and the slowest infusion rate possible. Dosage may be reduced if creatinine levels rise significantly.
Hepatic Impairment
No specific dosage adjustments are generally required for liver impairment, as IgG is not metabolized by the liver. However, patients with liver disease may be at higher risk for thrombosis (blood clots), requiring careful monitoring.
Elderly Patients
Patients over 65 years of age are at increased risk for adverse reactions, particularly renal dysfunction and thromboembolic events. Lower infusion rates and thorough hydration are mandatory for this population.
How to Take Human Immunoglobulin G
Human Immunoglobulin G is administered by a healthcare professional in a clinic, hospital, or through a home-infusion service.
Hydration: It is critical to be well-hydrated before the infusion begins. Drink plenty of water in the 24 hours leading up to your appointment.
Pre-medication: Your doctor may prescribe acetaminophen (Tylenol) and an antihistamine (like Benadryl) 30 to 60 minutes before the infusion to prevent common side effects like headache and fever.
Infusion Rate: The infusion must start very slowly (e.g., 0.01 mL/kg/minute). If tolerated, the nurse will gradually increase the rate every 15-30 minutes.
Storage: Most liquid formulations must be stored in the refrigerator (2°C to 8°C) and protected from light, though some brands allow for room-temperature storage for limited periods. Never shake the vial, as this can damage the proteins.
Missed Dose
If you miss an infusion appointment, contact your healthcare provider immediately to reschedule. Maintaining consistent trough levels (the lowest amount of drug in your blood before the next dose) is vital for preventing infections or disease flares. Do not double the dose at the next appointment to 'catch up.'
Overdose
An overdose of Human Immunoglobulin G is rare because it is administered by professionals, but it can lead to 'hyperviscosity syndrome' (thickening of the blood).
Symptoms: Severe headache, confusion, shortness of breath, or swelling in the legs.
Emergency Measures: Treatment involves stopping the infusion immediately and providing supportive care, which may include intravenous fluids to thin the blood.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or frequency without medical guidance. Regular blood tests are required to ensure the dose is effective and safe.
⚠️Side Effects
Common Side Effects (>1 in 10)
Side effects are most common during the first few infusions or when switching brands. These are often related to the rate of infusion.
Headache: This is the most frequently reported side effect. It can range from a mild tension-type headache to a severe migraine-like sensation. It usually begins toward the end of the infusion or a few hours later.
Fever and Chills: Often referred to as 'flu-like symptoms,' these typically resolve within 24 to 48 hours.
Fatigue: Many patients feel significantly tired or 'wiped out' for a day or two following treatment.
Injection Site Reactions: For subcutaneous (SCIG) users, redness, swelling, and itching at the needle site are very common but usually mild.
🔴Warnings
Important Safety Information
Human Immunoglobulin G is a complex biologic product. Patients must be screened for specific risk factors before the first dose. Because it is derived from human plasma, it carries a theoretical risk of transmitting infectious agents, although modern manufacturing processes make this risk extremely low.
Black Box Warnings
No FDA black box warnings are omitted here; they are central to the safety profile of Human Immunoglobulin G.
Renal Warning: Human Immunoglobulin G has been associated with renal dysfunction, acute renal failure, osmotic nephrosis, and death. Use with extreme caution in patients with any degree of renal insufficiency. Ensure patients are not volume-depleted before infusion.
Thrombotic Events Warning: Thrombosis (blood clotting) may occur with immune globulin products. Risk factors include advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling central vascular catheters, and hyperviscosity.
🔄Interactions
Contraindicated Combinations (Do Not Use Together)
There are no absolute drug-drug contraindications where the combination is guaranteed to be fatal; however, the following should be avoided:
Live Virus Vaccines (e.g., MMR, Varicella, Rotavirus): Human Immunoglobulin G contains antibodies that will neutralize the vaccine virus before your body can develop its own immunity. This renders the vaccine ineffective. Live vaccines should generally be delayed for at least 3 to 11 months after an IgG infusion.
Serious Interactions (Monitor Closely)
Loop Diuretics (e.g., Furosemide/Lasix): These drugs can cause dehydration, which significantly increases the risk of IgG-induced acute renal failure.
Nephrotoxic Agents (e.g., NSAIDs like Ibuprofen, Gentamicin, IV Contrast): Taking other drugs that stress the kidneys while receiving IgG can lead to sudden kidney collapse.
🚫Contraindications
Absolute Contraindications
There are specific scenarios where Human Immunoglobulin G must NEVER be used because the risks far outweigh any potential benefits:
History of Anaphylaxis to Immune Globulin: If a patient has had a life-threatening allergic reaction to any human immunoglobulin product in the past, they should not receive it again unless in a highly controlled desensitization setting.
Selective IgA Deficiency with Antibodies to IgA: Patients who lack IgA and have developed 'anti-IgA' antibodies can experience immediate, severe anaphylaxis upon receiving IgG, as most IgG products contain trace amounts of IgA.
Hyperprolinemia Type I: Certain brands of IgG (such as Privigen) use the amino acid L-proline as a stabilizer. Patients with this rare genetic metabolic disorder cannot process proline, making these specific brands contraindicated.
Relative Contraindications
👥Special Populations
Pregnancy
Human Immunoglobulin G is classified as FDA Pregnancy Category C (or B, depending on the specific brand). There are no well-controlled studies in pregnant women; however, clinical experience suggests that IgG does not cause birth defects.
Trimester-Specific Risks: IgG is known to cross the placenta, especially during the third trimester. This is often used therapeutically to treat conditions in the fetus, such as fetal alloimmune thrombocytopenia.
Clinical Use: It is frequently used during pregnancy to treat maternal ITP or to provide protection against infections in mothers with PI. The benefits usually outweigh the theoretical risks.
Breastfeeding
Immunoglobulins are a natural component of breast milk. While Human Immunoglobulin G passes into breast milk, it is unlikely to be absorbed by the infant's digestive tract in a way that would cause harm. Most experts consider IgG therapy compatible with breastfeeding, though the infant should be monitored for any unusual symptoms like diarrhea or skin rash.
🧬Pharmacology
Mechanism of Action
At the molecular level, Human Immunoglobulin G acts through several pathways:
1Antigen Binding: The Fab (Fragment, antigen-binding) portion of the IgG molecule binds to specific epitopes on pathogens, neutralizing them.
2Fc Receptor Blockade: In autoimmune diseases, the Fc (Fragment, crystallizable) portion of the infused IgG binds to Fc receptors on macrophages, preventing them from 'eating' the patient's own platelets or myelin.
3Complement Regulation: IgG can bind to and neutralize C3a and C5a (complement fragments), reducing the inflammatory cascade.
4Cytokine Modulation
Frequently Asked Questions
Common questions about Bivigam
What is Human Immunoglobulin G used for?
Human Immunoglobulin G is primarily used as a replacement therapy for people who have primary immunodeficiency diseases, meaning their bodies cannot produce enough antibodies to fight off infections. It is also used to treat several autoimmune disorders where the immune system mistakenly attacks the body's own tissues, such as Immune Thrombocytopenic Purpura (ITP) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). In some cases, it is used to prevent coronary artery damage in children with Kawasaki disease. By providing a broad spectrum of healthy antibodies from donors, it helps stabilize the immune system and provides passive protection against bacteria and viruses. Your healthcare provider will determine the specific use based on your blood work and clinical symptoms.
What are the most common side effects of Human Immunoglobulin G?
The most common side effects of Human Immunoglobulin G include headaches, fever, chills, and fatigue, which often feel like 'flu-like' symptoms. These reactions are most frequent during the first few hours of an infusion or shortly after it ends. Some patients also experience nausea, back pain, or joint aches during the administration process. For those receiving the medication subcutaneously (under the skin), redness and swelling at the injection site are very common. Most of these side effects are mild and can be managed by slowing the infusion rate or taking pre-medications like acetaminophen. However, you should always report any side effects to your nurse or doctor immediately.
Can I drink alcohol while taking Human Immunoglobulin G?
While there is no known direct chemical interaction between alcohol and Human Immunoglobulin G, it is generally advised to avoid alcohol for at least 24 hours before and after your infusion. Alcohol is a diuretic and can lead to dehydration, which significantly increases your risk of developing severe headaches and kidney strain during the treatment. Maintaining optimal hydration is one of the most effective ways to prevent the common side effects associated with IgG therapy. If you do choose to consume alcohol, discuss the timing with your doctor to ensure it does not interfere with your hydration goals. Always prioritize water and electrolyte-rich fluids on the day of your treatment.
Is Human Immunoglobulin G safe during pregnancy?
Human Immunoglobulin G is generally considered safe during pregnancy and is often used to treat pregnant women with immune disorders or to protect the fetus from certain blood-related conditions. It is classified by the FDA as Category C (or B, depending on the brand), meaning that while large-scale controlled studies are lacking, clinical experience has not shown a risk of birth defects. The antibodies in the medication actually cross the placenta and can provide the developing baby with extra protection. Many women have successfully used IgG therapy throughout their pregnancy under the close supervision of a high-risk obstetrician. Always discuss the risks and benefits with your healthcare team if you are pregnant or planning to become pregnant.
How long does it take for Human Immunoglobulin G to work?
The time it takes for Human Immunoglobulin G to work depends entirely on the condition being treated. For patients with bleeding disorders like ITP, an increase in platelet counts can often be seen within 24 to 72 hours after the first infusion. For those with neurological conditions like CIDP, it may take several weeks or multiple doses before a significant improvement in muscle strength or coordination is noticed. In the case of primary immunodeficiency, the medication begins providing protection against infection immediately, although it may take several months to reach a 'steady state' level in your blood. Your doctor will monitor your symptoms and blood levels to track how well the treatment is working for you.
Can I stop taking Human Immunoglobulin G suddenly?
You should never stop taking Human Immunoglobulin G suddenly without consulting your specialist. For patients with primary immunodeficiency, stopping the medication will leave the body without adequate protection against life-threatening infections, often within a few weeks as the infused antibodies naturally break down. For those with autoimmune conditions like CIDP, stopping treatment can lead to a rapid relapse of symptoms, including muscle weakness and loss of mobility. While there are no 'withdrawal' symptoms like those seen with some other drugs, the underlying disease will no longer be managed. If you need to stop therapy due to side effects or financial reasons, your doctor will help you develop a safe transition plan.
What should I do if I miss a dose of Human Immunoglobulin G?
If you miss an appointment for your Human Immunoglobulin G infusion, you should contact your healthcare provider or infusion center as soon as possible to reschedule. Consistency is key to maintaining a protective level of antibodies in your system, and delaying a dose can increase your risk of infection or cause a flare-up of your autoimmune symptoms. Do not attempt to 'double up' on your next dose or change your schedule without medical approval. Your doctor may want to check your IgG levels if the delay is significant. Most infusion schedules have a small window of flexibility, but it is best to stay as close to your prescribed dates as possible.
Does Human Immunoglobulin G cause weight gain?
Human Immunoglobulin G does not typically cause long-term weight gain or changes in body fat. However, some patients may experience temporary weight fluctuations due to fluid retention immediately following an infusion. Because the medication is a protein-rich solution, it can cause the body to hold onto extra water for a day or two, which might show up as a slight increase on the scale or swelling in the ankles. This is usually temporary and resolves as the body processes the infusion. If you notice rapid weight gain (several pounds in a single day) or significant swelling, contact your doctor, as this could be a sign of a heart or kidney issue. Long-term weight gain is more likely related to other medications, such as corticosteroids, often taken alongside IgG.
Can Human Immunoglobulin G be taken with other medications?
Human Immunoglobulin G can be taken with many other medications, but there are some important exceptions you must discuss with your doctor. It can interfere with the effectiveness of live virus vaccines, such as the MMR or chickenpox vaccines, so these must be timed carefully. It should also be used with caution if you are taking medications that can affect the kidneys, such as ibuprofen or certain antibiotics, as this can increase the risk of renal side effects. Additionally, if you use a blood glucose monitor, some IgG products can cause falsely high readings. Always provide your healthcare team with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you are using to ensure a safe treatment plan.
Is Human Immunoglobulin G available as a generic?
Human Immunoglobulin G is a complex biologic product derived from human plasma, which means it does not have 'generics' in the same way that simple chemical drugs like aspirin do. Instead, there are many different 'branded' versions produced by different manufacturers, such as Gammagard, Gamunex-C, Privigen, and Hizentra. While these products are similar, they are not always interchangeable because they have different stabilizers, pH levels, and concentrations. Some are designed for intravenous use, while others are for subcutaneous use. Your insurance company or doctor may prefer a specific brand based on your medical history and the specific condition being treated. If you need to switch brands, your doctor will monitor you closely for any new side effects.
Similar Medications
Other drugs with the same active ingredient (Human Immunoglobulin G)
Nausea and Vomiting: Mild gastrointestinal upset may occur during the infusion.
Back Pain or Joint Pain: A dull ache in the lower back or large joints.
Blood Pressure Changes: Both increases (hypertension) and decreases (hypotension) in blood pressure can occur during administration.
Tachycardia: A racing heart or palpitations.
Rare Side Effects (less than 1 in 100)
Aseptic Meningitis: A non-infectious inflammation of the lining of the brain. Symptoms include severe headache, neck stiffness, light sensitivity, and fever. It usually appears within 48 hours of an infusion and resolves without permanent damage.
Hemolytic Anemia: IgG can sometimes contain antibodies that cause the destruction of the patient's own red blood cells. Symptoms include pale skin, dark urine, and extreme weakness.
Transfusion-Related Acute Lung Injury (TRALI): A rare but serious lung reaction characterized by severe respiratory distress and low oxygen levels.
Serious Side Effects — Seek Immediate Medical Attention
> Warning: Stop taking Human Immunoglobulin G and call your doctor immediately if you experience any of these symptoms.
Anaphylaxis: Signs include hives, swelling of the throat or tongue, difficulty breathing, and fainting. This is most common in patients with IgA deficiency.
Thrombosis (Blood Clots): Look for pain, warmth, or swelling in one leg (DVT), sudden shortness of breath (PE), or signs of a stroke (slurred speech, one-sided weakness).
Acute Renal Failure: Signs include a sudden decrease in urination, swelling in the ankles or feet, and rapid weight gain.
Severe Skin Reactions: Stevens-Johnson Syndrome is extremely rare but possible; watch for a blistering rash or peeling skin.
Long-Term Side Effects
Prolonged use of Human Immunoglobulin G is generally considered safe, but patients should be monitored for:
Iron Overload: Rare, but can occur in patients receiving very high doses over many years.
Volume Overload: Chronic infusions can strain the heart in patients with pre-existing congestive heart failure.
Pathogen Transmission: While the risk is mathematically near zero due to modern screening, IgG is a human blood product, and the theoretical risk of transmitting infectious agents (including prions) exists.
Black Box Warnings
The FDA has issued several Black Box Warnings for Human Immunoglobulin G products:
1Renal Dysfunction and Acute Renal Failure: Cases of kidney failure and death have occurred, particularly with products containing sucrose as a stabilizer. Patients with pre-existing renal insufficiency, diabetes, or sepsis are at highest risk.
2Thrombosis: Blood clots may occur even in patients without risk factors. Risk is higher with high doses and rapid infusion rates.
Report any unusual symptoms to your healthcare provider. Most side effects can be managed by adjusting the infusion rate or changing the pre-medication regimen.
Major Precautions
Allergic Reactions / Anaphylaxis: Patients with selective IgA deficiency who have developed antibodies against IgA are at high risk for severe life-threatening allergic reactions. Testing for IgA levels is often performed before starting therapy.
Aseptic Meningitis Syndrome (AMS): This syndrome may occur more frequently with high doses (2 g/kg) or rapid infusion. It is characterized by severe headache, nausea, vomiting, and nuchal rigidity (stiff neck).
Hemolysis: IgG products can contain blood group antibodies that may act as hemolysins and induce in vivo coating of red blood cells with immunoglobulin, causing a positive direct antiglobulin test (Coombs' test) and hemolysis.
Hyperproteinemia: High levels of protein in the blood can lead to 'pseudohyponatremia' (a false low sodium reading on blood tests). This requires careful interpretation by a physician.
Monitoring Requirements
To ensure safety, your healthcare provider will require regular laboratory monitoring:
Renal Function: Baseline BUN and Serum Creatinine must be checked before starting and periodically thereafter.
Urine Output: Monitoring for any decrease in urination during and after the infusion.
Blood Counts: Complete Blood Count (CBC) to check for signs of hemolysis or infection.
Vital Signs: Blood pressure, heart rate, and temperature are monitored every 15-30 minutes during the infusion.
IgG Trough Levels: For PI patients, blood is drawn just before an infusion to ensure the dose is high enough to maintain protection.
Driving and Operating Machinery
Some patients experience dizziness or fatigue after an infusion. It is recommended that you do not drive or operate heavy machinery for at least 24 hours after your first few infusions until you know how the medication affects you.
Alcohol Use
There is no direct chemical interaction between alcohol and Human Immunoglobulin G. However, alcohol can cause dehydration, which significantly increases the risk of headaches and kidney strain during an infusion. It is best to avoid alcohol for 24 hours before and after treatment.
Discontinuation
Stopping Human Immunoglobulin G suddenly in patients with PI can lead to a rapid return of severe infections. In patients with CIDP or ITP, discontinuation may cause a relapse of symptoms. Always consult your specialist before stopping treatment. There is no 'withdrawal syndrome' in the traditional sense, but the underlying disease will no longer be suppressed.
> Important: Discuss all your medical conditions, especially kidney disease, heart disease, or a history of blood clots, with your healthcare provider before starting Human Immunoglobulin G.
Estrogen-Containing Contraceptives: Estrogen increases the risk of blood clots. When combined with the thrombotic risk of IgG, the danger of stroke or pulmonary embolism is heightened.
Moderate Interactions
Blood Thinners (Warfarin, Heparin): While not a direct interaction, the use of IgG in patients with bleeding disorders requires careful coordination with anticoagulation therapy.
Corticosteroids: Often used together, but long-term use of both can increase the risk of fluid retention and electrolyte imbalances.
Food Interactions
Hydration Status: The most important 'interaction' is with water. Dehydration increases the viscosity of the blood, making the side effects of IgG much more severe.
Salt Intake: High salt intake can contribute to fluid retention, which may complicate the infusion in patients with heart or kidney issues.
Herbal/Supplement Interactions
St. John’s Wort: While no direct interaction exists, St. John’s Wort can affect the metabolism of other medications you may be taking alongside IgG.
Licorice Root: Can cause sodium retention and potassium loss, potentially complicating the fluid balance required for safe IgG administration.
Lab Test Interactions
Human Immunoglobulin G can significantly interfere with several laboratory tests:
Serological Tests: After an infusion, your blood will test positive for many antibodies (like Hepatitis or Measles) that you didn't produce yourself. This can lead to false-positive results.
Blood Glucose: Some IgG products contain maltose, which can cause falsely high blood sugar readings on certain glucose meters. This can lead to dangerous over-administration of insulin.
Coombs' Test: IgG can cause a false-positive direct antiglobulin test, complicating blood typing and cross-matching.
Erythrocyte Sedimentation Rate (ESR): IgG may cause a transient rise in ESR that does not reflect a new infection.
For each major interaction, the management strategy involves either timing the medications differently (as with vaccines), ensuring aggressive hydration (as with diuretics), or using alternative testing methods (as with glucose monitoring).
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter pain relievers.
These are conditions where the doctor must perform a careful risk-benefit analysis:
Pre-existing Acute Renal Failure: If the kidneys are already failing, IgG may worsen the condition to the point of requiring dialysis.
Congestive Heart Failure (CHF): Because IgG is a protein-rich solution that draws fluid into the bloodstream, it can cause 'volume overload,' leading to acute heart failure or pulmonary edema (fluid in the lungs).
Hyperviscosity Syndromes: Patients with very high protein levels (like those with certain types of multiple myeloma) may have 'thick' blood that becomes dangerously viscous after an IgG infusion.
Cross-Sensitivity
Patients who are allergic to other blood-derived products (such as albumin or clotting factors) may have an increased risk of reacting to Human Immunoglobulin G. Additionally, some formulations contain trace amounts of detergents or chemicals used in the manufacturing process (like polysorbate 80); sensitivity to these components should be evaluated.
> Important: Your healthcare provider will evaluate your complete medical history, including any rare genetic disorders or previous reactions to blood transfusions, before prescribing Human Immunoglobulin G.
Pediatric Use
Human Immunoglobulin G is approved for use in children as young as newborns for certain indications (like Kawasaki Disease).
Growth Effects: There is no evidence that IgG therapy affects long-term growth or development.
Dosing: Dosing is strictly weight-based. Children are more susceptible to fluid shifts, so infusion rates must be carefully calculated and monitored.
Conditions NOT Approved: IgG is generally not used for 'frequent colds' or minor immune system delays in children unless a specific deficiency is diagnosed.
Geriatric Use
Patients over age 65 are at the highest risk for the most serious complications of IgG therapy.
Renal Risk: Age-related decline in kidney function makes elderly patients more prone to acute renal failure.
Thrombosis: The risk of stroke and heart attack is significantly higher in this population.
Administration: Slower infusion rates and lower concentrations (5% instead of 10%) are often recommended for geriatric patients.
Renal Impairment
In patients with a Glomerular Filtration Rate (GFR) below 60 mL/min/1.73m², IgG should be used with extreme caution.
Adjustments: The dose may not be changed, but the rate of administration is often halved.
Dialysis: IgG is a large molecule and is not significantly cleared by standard hemodialysis. Dosing does not usually need to be timed around dialysis sessions.
Hepatic Impairment
No dose adjustments are required for patients with liver disease (Child-Pugh Class A, B, or C). However, these patients should be monitored for 'hypercoagulability' (increased clotting risk), as the liver produces many of the body's natural anticoagulants.
> Important: Special populations require individualized medical assessment and often more frequent laboratory monitoring to ensure safety.
: It shifts the balance of the immune system from a pro-inflammatory state to an anti-inflammatory state by increasing the production of interleukin-10 (IL-10).
Pharmacodynamics
Onset of Effect: In ITP, platelet counts usually begin to rise within 24 to 72 hours. In PI, protection against infection is immediate upon reaching therapeutic levels.
Duration: The effects of a single dose typically last 3 to 4 weeks, which is why maintenance dosing is usually scheduled monthly.
Tolerance: There is no evidence of pharmacological tolerance; the drug remains effective over decades of use.
| Protein Binding | Minimal (it is a protein itself) |
| Half-life | 21 to 30 days |
| Tmax | Immediate (IV), 2-4 days (Subcutaneous) |
| Metabolism | Lysosomal Proteolysis |
| Excretion | Renal <1%, Fecal <1% (broken down into amino acids) |
Chemical Information
Molecular Formula: Complex glycoprotein (approx. C6332H9812N1688O1984S42 for IgG1)
Molecular Weight: Approximately 150,000 Daltons (150 kDa)
Solubility: Highly soluble in water-based solutions at slightly acidic pH (4.0 to 6.0)
Structure: A 'Y' shaped molecule consisting of two heavy chains and two light chains held together by disulfide bonds.
Drug Class
Human Immunoglobulin G is the primary member of the Human Immunoglobulin G [EPC] class. Related medications include specialized hyper-immune globulins (like RhoGAM for Rh-negative pregnancy or Rabies Immune Globulin), which contain high titers of antibodies against a single specific antigen.